El-Hattab-Schmidts syndrome UAE marks a milestone for the nation’s medical research as Prof Ayman W. El-Hattab at Burjeel Medical City has a third rare genetic disorder officially named after him. The neurodevelopmental condition affecting children’s brain development and muscle strength was identified through his team’s work since 2018, highlighting Abu Dhabi’s growing role in global genetics research.
This autosomal recessive disorder causes global developmental delay, intellectual disability, low muscle tone (hypotonia), feeding difficulties, coordination problems, seizures, eye issues, distinctive facial features and brain structure abnormalities visible on imaging. Early diagnosis through genetic testing enables targeted therapies improving quality of life.
El-Hattab-Schmidts Syndrome UAE: Discovery Timeline and Symptoms
Key Clinical Features:
| Symptom | Impact |
|---|---|
| Global developmental delay | Learning challenges |
| Low muscle tone (hypotonia) | Floppy infants, feeding issues |
| Intellectual disability | Cognitive impairment |
| Seizures | Neurological complications |
| Eye problems | Vision-related issues |
| Brain abnormalities | Visible on MRI scans |
The breakthrough began when Prof El-Hattab’s team identified PPP1R21 gene variants in three children with unexplained symptoms. Independent research by Dr Schmidts confirmed similar cases, leading to the syndrome’s formal naming honoring both discoverers.
El-Hattab-Schmidts Syndrome UAE: Prof El-Hattab’s Research Legacy
Jordanian-born Prof Ayman El-Hattab, Consultant Clinical Genetics and Director of Genetics and Rare Disease Center at Burjeel Medical City, has identified over 10 novel genetic syndromes. “Advances in genetic testing are helping us uncover more conditions and provide answers to families,” he emphasized, noting UAE’s rapid diagnostic progress.
Diagnosis Benefits:
-
Ends families’ diagnostic odyssey
-
Enables tailored neurological therapies
-
Supports IVF with pre-implantation genetic testing
-
Informs recurrence risk counseling
His message to affected families: “Do not give up. With rapid progress in this field, more diagnoses are becoming possible.”
El-Hattab-Schmidts Syndrome UAE: Why Abu Dhabi Leads Rare Disease Research
El-Hattab-Schmidts syndrome UAE discovery underscores Burjeel Medical City’s position at the forefront of genomic medicine, where advanced sequencing identifies disease-causing variants previously undetectable. The autosomal recessive inheritance pattern—where both parents carry silent mutations—highlights the importance of consanguinity screening common in Gulf populations.
For UAE families facing unexplained childhood neurological symptoms, Prof El-Hattab’s work offers hope through precision diagnosis and personalized management pathways.
Gulf Repost celebrates UAE medical milestones, rare disease research breakthroughs and Abu Dhabi healthcare innovation—your source for Emirates health and science news driving regional medical awareness.
